Cancer Immunology Miniatures
Leila Khoja, Catherine Maurice, MaryAnne Chappell, Leslie MacMillan, Ayman S. Al-Habeeb, Nada Al-Faraidy, Marcus O. Butler, Patrik Rogalla, Warren Mason, Anthony M. Joshua and David Hogg
Cancer Immunol Res March 1 2016 4 (3) 175-178; DOI:10.1158/2326-6066.CIR-15-0186
The patterns and kinetics of toxicity with anti–PD-1 agents are emerging. The incidence of grade 3 or above toxicities is low. We identify an idiosyncratic toxicity, eosinophilic fasciitis, that requires particular clinical vigilance to enable diagnosis and management.